Number of Shares
204,433.00
Current Holdings Value*
$14.45 Mil
% of Portfolio
0.5%
Total Estimate Gain
$-2.04 Mil
% of Total Estimate Gain
-14.85%

Thrivent Large Cap Value Portfolio's BioMarin Pharmaceutical Inc Holding Summary

As of 2025-03-31, THRIVENT SERIES FUND INC held 204,433.00 shares of BioMarin Pharmaceutical Inc(BMRN), totaling $14.45 Mil. This investment constitutes 0.5% of their stock portfolio, and THRIVENT SERIES FUND INC now holds 0.11% of the outstanding BioMarin Pharmaceutical Inc(BMRN) stock.

The initial trade took place in 2025Q1. And since then Thrivent Large Cap Value Portfolio has made 1 purchases of BMRN, at an average price of $67.28, for a total of 204,433.00 shares. Based on historical transaction data and BMRN's current price of $57.29, Thrivent Large Cap Value Portfolio's estimated gain on his BMRN holdings is $-2.04 Mil, reflecting a -14.85% gain to date.

Thrivent Large Cap Value Portfolio BMRN ($57.29) Holding Chart

Thrivent Large Cap Value Portfolio BMRN ($57.29) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1